PRESCRIPTION POINT LTD
PRESCRIPTION POINT LTD is a Private limited company (Ltd.) registered in United Kingdom under 08563110, and its current status with Companies House is active. The company was incorporated on 10 June 2013 and lists its registered address as Leeds, United Kingdom. 4 shareholders are on record for PRESCRIPTION POINT LTD, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 19 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Four shareholders are currently on record for PRESCRIPTION POINT LTD, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.
The largest of these is PHARMACY2U LIMITED, holding 25% — the largest recorded stake — followed by PHARMACY2U LIMITED at 25%; the remaining 2 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| PHARMACY2U LIMITED | 25% | Companies House | |
| PHARMACY2U LIMITED | 25% | Companies House | |
| PHARMACY2U LIMITED | 25% | Companies House | |
| PHARMACY2U LIMITED | 25% | Companies House |
Officers
5
The Director of PRESCRIPTION POINT LTD currently on record is PHILIP DAY; five officers are currently on record for PRESCRIPTION POINT LTD, filed with Companies House.
The register reports 7 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at PRESCRIPTION POINT LTD sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
PRESCRIPTION POINT LTD sits 2 levels below its ultimate parent, P2U HOLDINGS LIMITED, registered in United Kingdom. Immediately above PRESCRIPTION POINT LTD is PHARMACY2U LIMITED, holding 100% as filed in PRESCRIPTION POINT LTD's own shareholder record with Companies House. P2U HOLDINGS LIMITED sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document.
P2U HOLDINGS LIMITED
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns PRESCRIPTION POINT LTD?
Four shareholders are currently on record for PRESCRIPTION POINT LTD, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is PHARMACY2U LIMITED, holding 25% — the largest recorded stake — followed by PHARMACY2U LIMITED at 25%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is PRESCRIPTION POINT LTD's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for PRESCRIPTION POINT LTD is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does PRESCRIPTION POINT LTD have on record?
4 shareholders are shown on record for PRESCRIPTION POINT LTD.
What is PRESCRIPTION POINT LTD's company registration number?
PRESCRIPTION POINT LTD's registration number is 08563110, filed with Companies House in United Kingdom. Its current status on the register is active.
Is PRESCRIPTION POINT LTD still an active company?
PRESCRIPTION POINT LTD's status on Companies House is listed as active.
When was PRESCRIPTION POINT LTD incorporated?
PRESCRIPTION POINT LTD was incorporated on 10 June 2013, according to Companies House.
What is PRESCRIPTION POINT LTD's registered address?
The registered address on file for PRESCRIPTION POINT LTD is Leeds, United Kingdom.
What legal structure is PRESCRIPTION POINT LTD registered as?
PRESCRIPTION POINT LTD is registered as a Private limited company (Ltd.) in United Kingdom.
Who are the officers/directors of PRESCRIPTION POINT LTD?
The Director of PRESCRIPTION POINT LTD currently on record is PHILIP DAY; five officers are currently on record for PRESCRIPTION POINT LTD, filed with Companies House. Management authority at PRESCRIPTION POINT LTD sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does PRESCRIPTION POINT LTD have a parent company or subsidiaries?
PRESCRIPTION POINT LTD sits 2 levels below its ultimate parent, P2U HOLDINGS LIMITED, registered in United Kingdom.
Can Zavia monitor changes to PRESCRIPTION POINT LTD's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to PRESCRIPTION POINT LTD's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access PRESCRIPTION POINT LTD's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like PRESCRIPTION POINT LTD's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 19 October 2026.